Back

Impact of chronic kidney disease on mid-term prognosis of stable angina patients with high-dose or low-dose pitavastatin treatment: REAL-CAD sub-study

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Genetic Predisposition and Management of Dyslipidemia Drug therapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Mitsuru Abe

Kurashiki Central Hospital, Kurashiki (Japan)

2 More presentations in this session

Presentation thumbnail
Risk factors for the presence and development of Familial Dysbetalipoproteinemia in subjects from the general population with an APOE2E2 genotype
Ms B. Heidemann (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Optimal blood lipid levels counterbalance high polygenic risk of coronary artery disease in 130 000 individuals
Doctor G. Botta (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Genetic Predisposition and Management of Dyslipidemia

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
New trial evidence in the field of lipid management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources